Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.

Clostridium Difficile Vaccine Efficacy Trial

Phase 2B/3 Double-blinded Placebo-controlled

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors

A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now